Sign In
Buy INO
$0.677
+0.0210 (+3.20%)
At Close: Jul 31, 2026
Inovio Stock Is a Longshot Covid-19 Bet
11:51am, Thursday, 03'rd Sep 2020
Numerous well-funded coronavirus vaccines are rapidly proceeding through clinical trials. INO stock risks being left behind.
3 Heavily Shorted Coronavirus Vaccine Stocks
06:10am, Thursday, 03'rd Sep 2020
Short-sellers are betting against these stocks big time. But that could set up big opportunities for investors if these biotechs have positive news on the way.
Why Inovio Pharmaceuticals Stock Dropped Today
05:23pm, Wednesday, 02'nd Sep 2020
The biotech company continues to give up the gains it earned earlier this year.
Inovio shares tumbled 8% after short seller Muddy Waters says don't believe the COVID-19 vaccine hype
01:05pm, Wednesday, 02'nd Sep 2020
Inovio Pharmaceuticals Inc. shares INO, -7.88% slid 8% Wednesday, after Muddy Waters said it has taken a short position in the stock, which has been boosted this year by high hopes for its COVID-19 va
The Key Reasons Investors Should Avoid Inovio Pharmaceuticals Stock
11:47am, Wednesday, 02'nd Sep 2020
The first time I highlighted opportunity in Inovio Pharmaceuticals (NASDAQ:INO), it traded at just $4.86 a share. That was in late January.
9 Reasons Why The Race For Major COVID-19 Vaccine Revenues Has Greatly Narrowed
10:06am, Wednesday, 02'nd Sep 2020
The huge amount of Operation Warp Speed funding for its six vaccines has helped them become somewhat dominant leaders in the race for a sizable share of the market.
Better Coronavirus Stock: Inovio Pharmaceuticals or Novavax?
06:37am, Wednesday, 02'nd Sep 2020
One of these high-flying biotechs is set up to stand out over the long-term.
Competitive Advantages Of Inovio's COVID Vaccine Makes Current Low Price A Buying Opportunity
03:49pm, Tuesday, 01'st Sep 2020
Inovio's COVID-19 vaccine race is not run.
Why Inovio Stock Slipped Today
03:39pm, Tuesday, 01'st Sep 2020
The more important question is: Why have Inovio's shares fallen for several weeks now?
Novavax: COVID-19 Gave It Fuel, But It's Running Near Empty
02:15pm, Monday, 31'st Aug 2020
NVAX had run over 4,000% YTD at its peak. COVID-19 vaccine hype is giving it some much-needed fuel after failing two late-stage clinical trials in 2016 and 2019.
Is The Party Over for Inovio Stock? It Depends
01:55pm, Monday, 31'st Aug 2020
Nevertheless, while it's not out of the running just yet, it may be best not to take a gamble with INO stock. Sit on the sidelines for now, and wait for a more compelling entry point.
FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FT
12:47am, Monday, 31'st Aug 2020
The United States Food and Drug Administration is willing to expedite the COVID-19 vaccine authorization process, including granting emergency use authorization to a candidate before it completes lat
Has The COVID-19 Vaccine Stock Bubble Burst?
12:41pm, Sunday, 30'th Aug 2020
COVID-19 vaccine stocks have gotten slammed this month.
Are These the 3 Best Coronavirus Stocks to Buy Now?
08:08am, Saturday, 29'th Aug 2020
Looking at clinical trial data and other key elements offers us the answer.
How Moderna Will Fare After Posting Strong Clinical Results
03:37am, Friday, 28'th Aug 2020
Moderna posted strong clinical results that failed to lift shares. Phase 3 results will follow over the next two years.
